These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 36338894)

  • 21. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival.
    Solé C; Solà E; Huelin P; Carol M; Moreira R; Cereijo U; Mas JM; Graupera I; Pose E; Napoleone L; dePrada G; Juanola A; Fabrellas N; Torres F; Morales-Ruiz M; Farrés J; Jiménez W; Ginès P
    Liver Int; 2019 Jul; 39(7):1246-1255. PubMed ID: 30597709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research advances in pathophysiology and diagnosis and treatment of hepatorenal syndrome].
    Cui RB; Yan M
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):246-248. PubMed ID: 28494540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatorenal syndrome: a critical update.
    Wadei HM
    Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of living donor liver transplantation for patients with preoperative type 1 hepatorenal syndrome and acute hepatic decompensation.
    Chok KS; Fung JY; Chan SC; Cheung TT; Sharr WW; Chan AC; Fan ST; Lo CM
    Liver Transpl; 2012 Jul; 18(7):779-85. PubMed ID: 22290625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study).
    Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M;
    Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute kidney injury spectrum in patients with chronic liver disease: Where do we stand?
    Chancharoenthana W; Leelahavanichkul A
    World J Gastroenterol; 2019 Jul; 25(28):3684-3703. PubMed ID: 31391766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on hepatorenal Syndrome: Definition, Pathogenesis, and management.
    Habas E; Ibrahim AR; Moursi MO; Shraim BA; Elgamal ME; Elzouki AN
    Arab J Gastroenterol; 2022 May; 23(2):125-133. PubMed ID: 35473682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathophysiology, clinical features and management of hepatorenal syndrome.
    Garzia P; Ferri GM; Ilardi M; Messina FR; Amoroso A
    Eur Rev Med Pharmacol Sci; 1998; 2(5-6):181-4. PubMed ID: 10710816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of hepatorenal syndrome and liver transplantation.
    Memon I; Klein CL
    Curr Opin Organ Transplant; 2011 Jun; 16(3):301-5. PubMed ID: 21505341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatorenal syndrome: pathophysiology, diagnosis, and management.
    Simonetto DA; Gines P; Kamath PS
    BMJ; 2020 Sep; 370():m2687. PubMed ID: 32928750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Integrated Review of the Hepatorenal Syndrome.
    Ojeda-Yuren AS; Cerda-Reyes E; Herrero-Maceda MR; Castro-Narro G; Piano S
    Ann Hepatol; 2021; 22():100236. PubMed ID: 32846202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatorenal syndrome.
    Cárdenas A; Gines P
    Clin Liver Dis; 2006 May; 10(2):371-85, ix-x. PubMed ID: 16971267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.
    Velez JCQ; Therapondos G; Juncos LA
    Nat Rev Nephrol; 2020 Mar; 16(3):137-155. PubMed ID: 31723234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hepatorenal syndrome].
    Pŭrvanov P
    Khirurgiia (Sofiia); 2002; 58(2):34-9. PubMed ID: 12515019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of renal injury include hepatorenal syndrome in patients with decompensated liver cirrhosis].
    Li WG; Xu XY
    Zhonghua Gan Zang Bing Za Zhi; 2020 May; 28(5):381-385. PubMed ID: 32536052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of renal functions in patients of chronic liver disease.
    Aggarwal HK; Jain D; Singla S; Jain P
    Ren Fail; 2015; 37(9):1457-63. PubMed ID: 26338024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatorenal syndrome - update 2020.
    Krátká K; Libicherová P; Mejzlíková N; Rychlík I
    Vnitr Lek; 2020; 66(3):71-75. PubMed ID: 32972169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.